
Opinion|Videos|July 3, 2024
Investigational Therapies Paving New PNH Treatment Pathways
Dr Haumschild continues leading a discussion surrounding potential treatment advancements in the PNH landscape.
Advertisement
Video content above is prompted by the following:
- Looking towards the future, what advancements do you anticipate in the treatment landscape for PNH and other complement-driven rare diseases, particularly in relation to investigational therapeutics targeting the alternative pathway?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Government Shutdown Could Disrupt Health Care Access
2
White House, Pfizer Reach Agreement on Drug Discounts; Trump Announces TrumpRx
3
FDA Approves Remibrutinib for Chronic Spontaneous Urticaria
4
UC Davis Pharmacy Residents Conduct Impactful Research on Medication Management, Patient Care: Jeremiah J. Duby, PharmD, BCPS, BCCCP
5